Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSTP.L Regulatory News (STP)

  • There is currently no data for STP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

22 Mar 2021 10:00

RNS Number : 0170T
Stenprop Limited
22 March 2021
 

 

 

STENPROP LIMITED

(Registered in Guernsey)

(Registration number 64865)

LSE share code: STP JSE share code: STP

ISIN: GG00BFWMR296

("Stenprop" or the "Company")

 

 

DEALINGS BY A DIRECTOR OF THE COMPANY AND BY A PERSON DISCHARGING MANAGERIAL RESPONSIBILITY

 

 

22 March 2021

 

Shareholders are advised of the following information relating to the exercise of vested nil cost options and market value options and the subsequent disposals of ordinary shares of the Company received as a result of these transactions.

 

Clearance to deal was granted in respect of all dealings.

 

Name of director:

Patsy Watson

Transaction date:

19 March 2021

Class of securities:

Nil cost options

Number of securities:

850,102

Deemed price per security:

GBP 1.44

Deemed total value of the transaction:

GBP 1,224,146.88

Nature of transaction:

Off-market exercise of nil cost options

Nature and extent of director's interest:

Direct beneficial

 

Name of director:

Patsy Watson

Transaction date:

19 March 2021

Class of securities:

Ordinary shares

Number of securities sold:

425,000

Price per security:

GBP 1.44

Total value of the transaction:

GBP 612,000.00

Nature of transaction:

On-market sale

Nature and extent of director's interest:

Direct beneficial

 

Name:

Neil Marais

Position:

Director of Stenprop (Swiss) Limited and Stenprop Trafalgar Limited, being subsidiaries of Stenprop

Transaction date:

19 March 2021

Class of securities:

Market value options

Number of securities:

105,239

Price per security:

GBP 1.1171

Total value of the transaction:

GBP 117,562.49

Nature of transaction:

Off-market exercise of market value options

Nature and extent of director's interest:

Direct beneficial

 

Name:

Neil Marais

Position:

Director of Stenprop (Swiss) Limited and Stenprop Trafalgar Limited, being subsidiaries of Stenprop

Transaction date:

19 March 2021

Class of securities:

Ordinary shares

Number of securities sold:

105,239

Price per security:

GBP 1.44

Total value of the transaction:

GBP 151,544.16

Nature of transaction:

On-market sale

Nature and extent of director's interest:

Direct beneficial

 

The Company utilised treasury shares to settle the exercise of the nil cost options and market value options to the above participants. Following these transactions, the total number of treasury shares held by the Company is 12,866,950 and the total number of shares in issue less shares held in treasury is 285,908,225.

 

 

For further information:

Stenprop Limited +44(0)20 3918 6600

Paul Arenson (paul.arenson@stenprop.com)

Julian Carey (julian.carey@stenprop.com)

James Beaumont (james.beaumont@stenprop.com)

 

Numis Securities Limited (Financial Adviser) +44(0)20 7260 1000

Hugh Jonathan

Vicki Paine

 

FTI Consulting (PR Adviser) +44(0)20 3727 1000

Dido Laurimore

Richard Sunderland

Richard Gotla

Neel Bose

Stenprop@fticonsulting.com

 

Java Capital (JSE Sponsor) +27 (0)11 722 3050

 

About Stenprop:

Stenprop is a UK REIT listed on the LSE and the JSE. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to www.stenprop.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDKBBNCBKKBNB
Date   Source Headline
15th Feb 20065:32 pmRNSDirectors' Dealings
30th Dec 20057:00 amRNSInterim Results
22nd Nov 20052:33 pmRNSResidential VoIP Agreement
7th Nov 20057:00 amRNSVoIP Agreements
1st Nov 20057:00 amRNSAgreement with Affiniti
10th Oct 20057:00 amRNSAgreement
14th Sep 20053:21 pmRNSNotification of Shareholding
2nd Sep 200511:08 amRNSGrant of Options
1st Aug 20059:30 amRNSDirectors' Share Purchases
29th Jul 20057:02 amRNSFinancial Results
21st Jul 20057:01 amRNSDirectorate Change
8th Jul 20058:54 amRNSGrant of Options
8th Jun 20057:00 amRNSEntacall Agreement
23rd May 20057:02 amRNSSigns New Agreement
11th May 20057:01 amRNSVirtual PBX Deal
10th May 20057:00 amRNSChange of Address
26th Apr 20057:01 amRNSDirectorate Change
6th Apr 20057:00 amRNSBroker Appointment
5th Apr 20053:36 pmRNSPlacing of Shares
15th Feb 20057:00 amRNSNew Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.